1Gerber PD, Barrett JE, Barrett JA, et al. The relationship of presenting physical complaints to depressive symptoms in primary care patients[J]. J Gen Intern Med, 1992,7 (2) : 170.
2Goldstein D J, Lu Y, Detke M J, et al. Effects of duloxetine onpainful physical symptoms associated with depression[J]. Psychosomatics, 2004,54(4) : 17.
3Mallinckrodt CH, Goldstein D J, Detke M J, et al. Duloxetine: a new treatment for the emotional and physical symptoms of depression[J]. Prim Care Companion J Clin Psychiatry,2003,5( 1 ) : 19.
4Hirschfeld RM, Vomik LA. Newer antidepressants: reviews of efficacy and safety of escitalopram and duloxetine [J]. J Clin Psychiatry, 2004,65 ( suppl 4 ) : 46.
5Kurt K, Robert LS, Janet BW. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms[J]. Psychosomatic Medicine, 2002,64 (2) ..258.
6Detke MJ, Lu Y, Goldstein DJ, et al. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized doubleblind placebo-controlled trial[J]. J Clin Psychiatry, 2002,63 (4) : 308.
7Lesley MA, Yili L, Leslie JC, et al. A doubleblind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder[J]. Arthritis Rheumatism, 2004, 50 (9):2 974.
8Spielmans CI. Duloxetine does not relieve painful physical symptoms in depression: a meta-analysis[J]. Psychother Psychosom, 2008,77( 1 ) : 12.
9Lott RS, Baker DE. Duloxetine.. a new antidepressant[J]. Advances in Pharmacy, 2003,1 (3) : 228.
10Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression[J]. Arch Gen Psychiatry, 1997,54(7) :597.
